
Pubmed-entry ::= {
  pmid 29191554,
  medent {
    em std {
      year 2017,
      month 12,
      day 2,
      hour 6,
      minute 0
    },
    cit {
      title {
        name "Structure-based design, synthesis, and binding mode analysis of
 novel and potent chymase inhibitors."
      },
      authors {
        names std {
          {
            name ml "Futamura-Takahashi J",
            affil str "Asubio Pharma Co., Ltd, 6-4-3 Minatojima-Minamimachi,
 Chuo-ku, Kobe 650-0047, Japan. Electronic address:
 futamura.junko.b6@asubio.co.jp."
          },
          {
            name ml "Tanaka T",
            affil str "Asubio Pharma Co., Ltd, 6-4-3 Minatojima-Minamimachi,
 Chuo-ku, Kobe 650-0047, Japan."
          },
          {
            name ml "Sugawara H",
            affil str "Asubio Pharma Co., Ltd, 6-4-3 Minatojima-Minamimachi,
 Chuo-ku, Kobe 650-0047, Japan."
          },
          {
            name ml "Iwashita S",
            affil str "Asubio Pharma Co., Ltd, 6-4-3 Minatojima-Minamimachi,
 Chuo-ku, Kobe 650-0047, Japan."
          },
          {
            name ml "Imajo S",
            affil str "Asubio Pharma Co., Ltd, 6-4-3 Minatojima-Minamimachi,
 Chuo-ku, Kobe 650-0047, Japan."
          },
          {
            name ml "Oyama Y",
            affil str "Asubio Pharma Co., Ltd, 6-4-3 Minatojima-Minamimachi,
 Chuo-ku, Kobe 650-0047, Japan."
          },
          {
            name ml "Muto T",
            affil str "Asubio Pharma Co., Ltd, 6-4-3 Minatojima-Minamimachi,
 Chuo-ku, Kobe 650-0047, Japan. Electronic address:
 muto.tsuyoshi.ba@asubio.co.jp."
          }
        }
      },
      from journal {
        title {
          iso-jta "Bioorg. Med. Chem. Lett.",
          ml-jta "Bioorg Med Chem Lett",
          issn "1464-3405",
          name "Bioorganic & medicinal chemistry letters"
        },
        imp {
          date std {
            year 2018,
            month 1,
            day 15
          },
          volume "28",
          issue "2",
          pages "188-192",
          language "eng",
          pubstatus ppublish,
          history {
            {
              pubstatus received,
              date std {
                year 2017,
                month 10,
                day 5
              }
            },
            {
              pubstatus revised,
              date std {
                year 2017,
                month 11,
                day 14
              }
            },
            {
              pubstatus accepted,
              date std {
                year 2017,
                month 11,
                day 15
              }
            },
            {
              pubstatus pubmed,
              date std {
                year 2017,
                month 12,
                day 2,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2018,
                month 2,
                day 17,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus other,
              date std {
                year 2017,
                month 12,
                day 2,
                hour 6,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pubmed 29191554,
        pii "S0960-894X(17)31118-6",
        doi "10.1016/j.bmcl.2017.11.031",
        other {
          db "ELocationID pii",
          tag str "S0960-894X(17)31118-6"
        },
        other {
          db "ELocationID doi",
          tag str "10.1016/j.bmcl.2017.11.031"
        }
      }
    },
    abstract "Based on insight from the X-ray crystal structure of human
 chymase in complex with compound 1, a lactam carbonyl of the diazepane core
 was exchanged with O-substituted oxyimino group, leading to amidoxime
 derivatives. This modification resulted in highly potent chymase inhibitors,
 such as O-phenylamidoxime 5f. X-ray crystal structure analysis indicated that
 compound 5f induced movement of the Leu99 and Tyr94 side chains at the S2
 site, and the increase in inhibitory activity of O-phenyl amidoxime
 derivatives suggested that the O-phenyl moiety interacted with the Tyr94
 residue. Surface plasmon resonance experiments showed that compound 5f had
 slower association and dissociation kinetics and the calculated residence
 time of compound 5f to human chymase was extended compared to that of amide
 compound 1.",
    mesh {
      {
        term "Binding Sites",
        qual {
          {
            subh "drug effects"
          }
        }
      },
      {
        term "Chymases",
        qual {
          {
            mp TRUE,
            subh "antagonists & inhibitors"
          },
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Dose-Response Relationship, Drug"
      },
      {
        mp TRUE,
        term "Drug Design"
      },
      {
        term "Humans"
      },
      {
        term "Molecular Structure"
      },
      {
        term "Oximes",
        qual {
          {
            subh "chemical synthesis"
          },
          {
            subh "chemistry"
          },
          {
            mp TRUE,
            subh "pharmacology"
          }
        }
      },
      {
        term "Serine Proteinase Inhibitors",
        qual {
          {
            subh "chemical synthesis"
          },
          {
            subh "chemistry"
          },
          {
            mp TRUE,
            subh "pharmacology"
          }
        }
      },
      {
        term "Structure-Activity Relationship"
      }
    },
    substance {
      {
        type nameonly,
        name "Oximes"
      },
      {
        type nameonly,
        name "Serine Proteinase Inhibitors"
      },
      {
        type nameonly,
        name "amidoxime"
      },
      {
        type ec,
        cit "3.4.21.39",
        name "Chymases"
      }
    },
    pmid 29191554,
    pub-type {
      "Journal Article"
    },
    status medline
  }
}


